Request a Quote

Blog

Specimen Insight Podcast

Specimen Insight podcast: Fast-Tracking Liquid Biopsy Development

September 12, 2019

Liquid biopsies are among the most exciting areas of medical diagnostics. Although the technology is in its early stages, the hope is that liquid biopsies – through a simple draw of blood or other human biofluids – will detect cancer earlier and without the invasiveness of surgical or needle biopsies. The procedure could one day be simple and cost-effective enough to conduct in the doctor’s office or in the comfort of one’s own home, even before symptoms arise.

Read More

Eric Langlois, Senior VP of Business Development

Five questions with Eric Langlois

September 5, 2019

Eric is iSpecimen’s senior vice president of sales and business development. Learn more about him as he answers 5 questions!

Read More

Wayne Vaz head shot

Five questions with Wayne Vaz

August 22, 2019

Wayne joined iSpecimen in June as Vice President of Growth and Corporate Development. He drives go-to-market strategies, key partnerships, and other initiatives that grow the iSpecimen Marketplace.

Read More

petri dish of cell culture

Specimen Spotlight: ‘Matched Sets’ of Biospecimens Give Researchers Deep Insights

August 15, 2019

A disease is an abnormal condition, and to fully understand it, you need to compare abnormal biology against the normal. That’s the concept behind the matched sets of human biospecimens that we provide to researchers around the world.

Read More

Two people looking out over mountain

Mixed News From the Alzheimer’s Research Front

August 8, 2019

Alzheimer’s disease remains stubbornly resistant to cures, though some progress is being made, especially on the diagnostic side. “We don’t have a lot of positive news these days,” Martin Tolar, CEO of Alzheon, told STAT  for a story on last month’s Alzheimer’s Association International Conference in Los Angeles. “But I do believe there’s a lot […]

Read More

Doctors examining patient x rays

Precision Medicine Has A Long Way to Go: A Need for Patient and Biospecimen Data

August 1, 2019

A human biospecimen is a potential font of biological data—data that when aggregated in enormous volumes and crunched by artificial intelligence drives the development of precision medicine. By analyzing genetic profiles of patients and tumors, and by matching mutations to targeted drugs, precision medicine is halting or reversing cancer…in a small fraction of cases.

Read More

Precision Medicine Depends on Patient and Research Diversity

July 25, 2019

As medical researchers steadily amass knowledge of the human genome, there’s a stubborn blind spot: Most genomic research arises from subjects of white European descent. In 2,500 recently published human genomics papers reviewed in one recent study, only 19% of the participants were of non-European ancestry. The diversity deficit is a problem: At stake is […]

Read More

Five Questions with Healthcare Data Expert Dave John

July 18, 2019

Dave John joined iSpecimen last month as vice president of product management. Dave is a life sciences data and informatics expert with extensive experience developing solutions for genomics, translational medicine, clinical trials and electronic health records. He will help shape future capabilities of the iSpecimen Marketplace. 1. You are a data expert. How does data […]

Read More

blood sample tube

Human Biofluids: Fueling Liquid Biopsies for Non-Invasive Cancer Detection

July 11, 2019

Biofluids – including blood, plasma, saliva, urine and even cheek swabs – can tell us a lot about a person’s health, which is why patients are routinely asked to provide these samples in the lab for testing. With a small amount of blood, for example, complex testing and screening of its chemistry, enzymes, lipoproteins and […]

Read More

yellow pills

Learning from the Past: The Fight against Opioid Addiction

July 2, 2019

What makes one person able to take painkillers without incident while another becomes addicted, and a third overdoses and dies? New Jersey researchers are exploring these questions, using a first-of-its-kind biobank of brains and blood samples from opioid users.   In a three-year, $4 million study, researchers and clinicians from the Coriell Institute for Medical […]

Read More

Previous   |